AKT1 and oropharynx squamous cell carcinoma: The molecular mechanism through which rapamycin inhibits the growth and proliferation of oral and oropharyngeal squamous cell carcinoma may lie in the inhibition of the PI3K/Akt/mTOR signalling pathway.